Weekly review in ophthalmology: 29 October-3 November
November 04, 2022
An end-of-week review of what happened in ophthalmology from 29 October to 3 November 2022.
© 2022 MJH Life Sciences™ and Opthalmology Times Europe. All rights reserved.
Inflammation & Infection
The pathophysiology and pathomorphology of corneal ectasia: Part 4
November 14, 2022
Corneal cross-linking (CXL) is improving all the time, although all protocols retain the basic requirements for oxygen, riboflavin and UV light. Recent developments mean that CXL at the slit lamp is feasible, which will improve access to the procedure.
Identifying herpes simplex virus keratitis in keratoconus surgery patients
November 03, 2022
One clinician advises investigating prospective patients for history and evidence suggesting HSV keratitis, and monitoring for post-surgery epithelial defects.
Comparing dry eye disease in adult and paediatric populations via the IRIS Registry
October 01, 2022
Almost 5 million patients in the IRIS Registry had received at least one diagnosis of DED between 2013 and 2019; of those, 203,171 were children under 18 years of age and 4,592,808 were adults.
Circumnavigating the bumpy road to vernal keratoconjunctivitis: Time is key
September 19, 2022
Ophthalmologists should look past the eyes in patients presenting with a persistent ocular allergic response and be mindful that sight-threatening vernal keratoconjunctivitis is a possibility.
Monkeypox may be linked with conjunctivitis
September 14, 2022
Spanish investigators hypothesise that conjunctivitis plays a role in disease transmission.
Time is retina: Focus on the ocular aspects of neuromyelitis optica
September 08, 2022
Symptoms of acute optic neuritis resulting from the disease can resolve in treated rapidly.
Short-term corticosteroid use can provide rapid relief of allergy symptoms in dry eye disease
August 29, 2022
A short course of a low-dose corticosteroid eye drop can relieve inflammation with only a low increase in intraocular pressure.
No ocular manifestations associated with inflammatory bowel disease, study finds
August 14, 2022
In a study, investigators found that no characteristics of inflammatory bowel disease are related to ocular manifestations of the disease.
Phase 3 study of CPN-302: Positive topline results for post-cataract surgery drug candidate
August 13, 2022
The companies note that data from Study CPN-302 confirm the results in the first Phase 3 study, CPN-301, and they demonstrate the clear benefits of treating patients after cataract surgery with APP13007.
Advertisement
Advertisement